Covid Vaccines May Only Stop Covid Symptoms: Yuen

"); jQuery("#212 h3").html("

Related News Programmes

"); });

2020-12-25 HKT 13:52

Share this story

facebook

  • Yuen Kwok-yung and his research team analyse the three coronavirus vaccines procured by the government in a newspaper article. Photo: RTHK

    Yuen Kwok-yung and his research team analyse the three coronavirus vaccines procured by the government in a newspaper article. Photo: RTHK

Government adviser Yuen Kwok-yung said on Friday that the three types of coronavirus vaccines procured by the government may not be able to help Hong Kong avoid asymptomatic infections, but he stressed there is still an urgent need for everyone to get inoculated.

The University of Hong Kong microbiologist explained that early lab tests showed the vaccines could trigger the production of neutralizing antibodies to prevent a person from developing symptoms or complications after being infected, but they could not stop a person from releasing the virus and infecting others.

Still, Yuen highlighted that efforts to help Hong Kong develop herd immunity should get underway as soon as possible.

"There is an imminent need to launch a universal innoculation programme," Yuen wrote with his research team in the Chinese-language Ming Pao newspaper.

Yuen, who is a member of the government's independent advisory panel on Covid-19 vaccines, also suggested that vaccines produced by Fosun-BioNtech and the mainland's Sinovac could be better options to be introduced in Hong Kong first.

He noted that trial results out so far for the Sinovac vaccine showed that it carries the fewest side-effects, but is expected to offer a shorter protection period.

But he stressed that the government must wait for Sinovac's late-stage trial results, which will not be released until next month after a delay, and conduct a thorough analysis before deciding to use its vaccine.

As for the vaccine developed by Fosun and BioNTech, Yuen said clinical trials showed that it is relatively safe and also offers good protection.

But he said it is necessary to observe the third option by Oxford University and AstraZeneca for a longer period of time for any side effects, noting that two people who earlier received the jabs had developed a neurological disorder.

Yuen urged the government to boost public confidence in inoculating against the coronavirus by being transparent.

"The inoculation scheme must aim to be quick, widespread, open and with choices for people to pick," he said.

RECENT NEWS

ZA Bank Brings Nasdaq Data To Hong Kong, Expanding US Stock Access And Investor Education

ZA Bank and Nasdaq have announced a collaboration aimed at enhancing digital wealth management in Hong Kong and interna... Read more

Hong Kong To Study One‑Stop Infrastructure For Equities, Bonds And Digital Assets

The Hong Kong Monetary Authority’s (HKMA) CMU OmniClear and the Hong Kong Exchange (HKEX) are set to begin a study on... Read more

Hong Kong To Issue First Stablecoin Licenses In March, Expand Crypto Regulation

Hong Kong will issue its first licenses for fiat-referenced stablecoin issuers in March and introduce new legislation l... Read more

MSIG Joins US$6B IFC Credit Insurance Facility To Boost Emerging Market Lending

MSIG USA and Mitsui Sumitomo Insurance (MSI Japan), together referred to as MSIG, have joined a new insurance-ba... Read more

Why The $2 Trillion Stablecoin Prediction Is Too Low

McKinsey estimates the stablecoin market will hit $2 trillion by 2028. But according to Sam Lin, COO of dtcpay, even th... Read more

RedotPay Eyes US IPO With Potential US$1 Billion Raise

RedotPay is reportedly exploring an IPO in the US that could raise more than US$1 billion, according to people famili... Read more